SAHPRA MedSafetyWeek campaign: Reporting of Side Effects

By HEOR Staff Writer

November 11, 2023

SAHPRA MedSafetyWeek campaign

The Importance of Documenting Side Effects

The South African Health Products Regulatory Authority (SAHPRA) is advocating for the usage of the MedSafety app as a means of bolstering efforts to ensure the integrity of medicinal products. #MedSafetyWeek is a global campaign that aims to improve the safety of medications all around the world, and this project is a component of that campaign. The campaign, involving more than 80 regulatory agencies, is a testament to the collective effort to better the healthcare industry.

 

SAHPRA MedSafetyWeek campaign: A Tool for Safer Medicines

Patients, physicians, nurses, and pharmacists are all able to report adverse effects with the help of a powerful tool called the MedSafety app. These reports are absolutely necessary for the continuous monitoring of the medications’ safety. According to Mafora Matlala, the Pharmacovigilance Manager at SAHPRA, “Every report is important in building more knowledge and understanding of the benefits and risks of medicines in clinical use and allows action to be taken to minimise risks.”

Users can download the MedSafety app from the Google Play Store or the Apple App Store, depending on your device. The app allows users to report adverse events and product quality issues. This helps enhance the safety of the healthcare environment overall.

SAHPRA’s commitment to the safety, efficacy, and quality of all health products underlines its ethos. Together, we can make a difference in ensuring safer medicines for all.

Reference url

Recent Posts

AI Regulatory Research Priorities
AI Regulatory Research Priorities in Medicine Lifecycle Management

By João L. Carapinha

June 12, 2026

AI Regulatory Research Priorities have crystallised around one central requirement: establishing trustworthy performance of artificial intelligence systems across the entire pharmaceutical development and evaluation pathway. Stakeholders from every corner of the European medicines regulatory netw...
health economic security
Health Economic Security as a Pillar for Growth in Central and Eastern Europe

By HEOR Staff Writer

June 12, 2026

Central and Eastern European nations face intensifying demographic pressures, including rapid population aging, shrinking workforces, and heightened security risks that endanger long-term prosperity. In a recent EFPIA statement, health economic security is seen as essential, as targeted healthcar...
gene therapy reimbursement
Gene Therapy Reimbursement Strategies for Vision Restoration

By HEOR Staff Writer

June 12, 2026

Gene therapy reimbursement in the Netherlands has demonstrated clear clinical value since the 2021 conditional access agreement for voretigene neparvovec (Luxturna®). Five years of structured real-world use confirmed that carefully designed protocols successfully selected appropriate patients wit...